Pfizer, BioNTech Announce Top-line Results In Phase 3 Trial Of MRNA-based Combination Vaccine

Retrieved on: 2024-08-16 16:12:50

Tags for this article:

RNA vaccines

COVID-19 vaccination in the United States

Walvax COVID-19 vaccine

COVID-19 vaccine clinical research

BioNTech SE

Pfizer Inc.

Click the tags to see associated articles and topics

Pfizer, BioNTech Announce Top-line Results In Phase 3 Trial Of MRNA-based Combination Vaccine. View article details on hiswai:

Excerpt

Drug giant Pfizer Inc. (PFE) and BioNTech SE (BNTX) announced Friday top-line results from their Phase 3 clinical trial to evaluate the companies' ...

Article found on: www.rttnews.com

View Original Article